The effects of acute and repeated doses of moclobemide on psychomotor performance and cognitive function in healthy elderly volunteers-Reference-Cited by-同舟云学术

The effects of acute and repeated doses of moclobemide on psychomotor performance and cognitive function in healthy elderly volunteers

Published:1992-07 Issue:4 Volume:7 Page:273-279
ISSN:0885-6222
Container-title:Human Psychopharmacology: Clinical and Experimental
language:en
Short-container-title:Hum. Psychopharmacol. Clin. Exp.

Author:

Kerr J. S.,Fairweather D. B.,Hindmarch I.

Publisher

Wiley

Subject

Pharmacology (medical),Psychiatry and Mental health,Clinical Neurology,Neurology

Reference32 articles.

1. and (1990). Measuring the effects of psychoactive drugs, with particular reference to antidepressants. In: Microcomputers, Psychology and Medicine, and (eds) John Wiley & Sons, Chichester, pp. 85-95.

2. Comparison of the monoamine oxidase inhibiting properties of two reversible and selective monoamine oxidase-A inhibitors moclobemide and toloxatone, and assessment of their effect on psychometric performance in healthy subjects.

3. Evaluation and comparison of the interaction between alcohol and moclobemide or clomipramine in healthy subjects

4. Clinical Pharmacokinetics of Hypnotics

5. Increased sensitivity to nitrazepam in old age.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute Alertness-Promoting Effects of a Novel Histamine Subtype-3 Receptor Inverse Agonist in Healthy Sleep-Deprived Male Volunteers;Clinical Pharmacology & Therapeutics;2010-10-27

2. Cognitive toxicity of pharmacotherapeutic agents used in social anxiety disorder;International Journal of Clinical Practice;2009-07

3. Next‐day cognition, psychomotor function, and driving‐related skills following nighttime administration of eszopiclone;Human Psychopharmacology: Clinical and Experimental;2008-07

4. A double-blind, placebo- and positive-internal-controlled (alprazolam) investigation of the cognitive and psychomotor profile of pregabalin in healthy volunteers;Psychopharmacology;2005-10-05

5. Therapeutic Applications of Selective and Non-Selective Inhibitors of Monoamine Oxidase A and B that do not Cause Significant Tyramine Potentiation;NeuroToxicology;2004-01